Two-year outcome of the ISKDC Regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 5, 2013, Pages 756-762

  Nakanishi, Koichi ^a   Iijima, Kazumoto ^b   Ishikura, Kenji ^c   Hataya, Hiroshi ^c   Nakazato, Hitoshi ^d   Sasaki, Satoshi ^e   Honda, Masataka ^c   Yoshikawa, Norishige ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN CHILDREN'S MEDICAL CENTER   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; PREDNISOLONE; SODIUM; CORTICOSTEROID;

ARTICLE; CHILD; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTEINURIA; RECURRENT DISEASE; SCHOOL CHILD; SEX RATIO; AGE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; JAPAN; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; REMISSION; RISK FACTOR; TIME; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; AGE FACTORS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; NEPHROTIC SYNDROME; PREDNISOLONE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; REMISSION INDUCTION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84877661350     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09010912     Document Type: Article

References (21)

1. van Husen M, Kemper MJ: New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol 26: 881-892, 2011
2. Tarshish P, Tobin JN, Bernstein J, Edelmann CM: Prognostic significance of the early course of minimal change nephrotic syndrome: Report of the International Study of Kidney Disease in Children. J Am Soc Nephro l8: 769-776, 1997
3. Ueda N, Chihara M, Kawaguchi S, Niinomi Y, Nonoda T, Matsumoto J, Ohnishi M, Yasaki T: Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome. J Pediatr 112: 122-126, 1988
4. Eh rich J H, Brodehl J: Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Padiatrische Nephrologie. EurJ Pediatr 152: 357-361, 1993
5. Ksiazek J, Wyszynska T: Short versus long initial prednisone treatment in steroid-sensitive nephrotic syndrome in children. Acta Paediatr 84: 889-893, 1995
6. Bagga A, Hari P, Srivastava RN: Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome. Pediatr Nephrol 13: 824-827, 1999
7. Hodson EM, Willis NS, Craig JC: Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev 17: CD001533, 2007
8. International Study of Kidney Disease in Children: Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the International Study of Kidney Disease in Children. J Pediatr 101: 514-518, 1982
9. Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A: A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259-263, 1976
10. Cox DR, Oakes D: Analysis of Survival Data, London, Chapman & Hall, 1984
11. Hodson EM, Alexander SI: Evaluation and management of steroid-sensitive nephrotic syndrome. CurrOpin Pediatr20: 145-150, 2008
12. Hodson EM, Craig JC, Willis NS: Evidence-based management of steroid-sensitive nephrotic syndrome. Pediatr Nephrol20:1523-1530, 2005
13. Hodson EM, Willis NS, Craig JC: Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database Syst Rev 23: CD002290, 2008
14. MacHardy N, Miles PV, Massengill SF, Smoyer WE, Mahan JD, Greenbaum L, Massie S, Yao L, Nagaraj S, Lin JJ, Wigfall D, Trachtman H, Hu Y, Gipson DS: Management patterns of childhood-onset nephrotic syndrome. Pediatr Nephrol 24: 2193-2201, 2009
15. White RH, Glasgow EF, Mills RJ: Clinicopathological study of nephrotic syndrome in childhood. Lancet 1: 1353-1359, 1970
16. Hiraoka M, Tsukahara H, Haruki S, Hayashi S, Takeda N, Miyagawa K, Okuhara K, Suehiro F, Ohshima Y, Mayumi M; The West Japan Cooperative Study of Kidney Disease in Children: Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. Kidney Int 58: 1247-1252, 2000
17. International Study of Kidney Disease in Children: The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children.J Pediatr 98: 561-564, 1981
18. International Study of Kidney Disease in Children: Nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13: 159-165, 1978
19. Yap HK, Han EJ, Heng CK, Gong WK: Risk factors for steroid dependency in children with idiopathic nephrotic syndrome. Pediatr Nephrol 16: 1049-1052, 2001
20. International Study of Kidney Disease in Children: Nephrotic syndrome in children: A randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the International Study of Kidney Disease in Children.J Pediatr 95: 239-243, 1979
21. Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H: Prediction of relapse by plasma lipoprotein(a) concentration in children with steroid-sensitive nephrotic syndrome. Nephron 92: 807-811, 2002